Synvitrobio has rebranded as Tierra Biosciences and raised $2.6m from Social Capital, Fifty Years, Kdt Ventures and angel investors, as it looks to develop agricultural and biochemical products using cell-free manufacturing. Tierra Biosciences is collaborating with the US Department of Energy's research institution to create vanilla extract and turpentine from biomass. Meanwhile, Sutro Biopharma is using cell-free technology for cancer and autoimmune disorders, while Genomatica is looking to grow chemicals used in Synvitrobio from a cell-free system and GreenLight Biosciences is developing a calorie-free sugar substitute.
Synvitrobio has rebranded as Tierra Biosciences and raised $2.6m from Social Capital, Fifty Years, Kdt Ventures and angel investors, as it looks to develop agricultural and biochemical products using cell-free manufacturing. Tierra Biosciences is collaborating with the US Department of Energy's research institution to create vanilla extract and turpentine from biomass. Meanwhile, Sutro Biopharma is using cell-free technology for cancer and autoimmune disorders, while Genomatica is looking to grow chemicals used in Lycra from a cell-free system and GreenLight Biosciences is developing a calorie-free sugar substitute.